The fund offers marketlike exposure to global pharmaceutical, biotechnology, and medical device companies. The underlying index is selected and weighted by float-adjusted market-cap. It pulls from the S&P Global 1200 universe, which effectively screens out small-caps, giving the fund a large-cap tilt. Aside from that, geographic and sector weights look neutral and make it a viable entry-point to g… read more
IShares
ETF
Equity
- years
93 holdings
$63.64
Price+0.27%
$0.17
$458.257m
Small
$6.380k
Avg Volume$637.788m
$74.28
NAV0.63%
Expense Ratio3.74%
Yield$2.38
Dividend